Member Info for GordonGecko123

Some are too busy talking rubbish to notice the chance to make money ,they can't see things have changed and shorts closing and now going long and take the opportunity because they are so narrow minded and stuck repeating the same rubbish . Sales will come and the chances of a takeover increase as they approach Fda. They don't need cash for another 18 months m take the hint or just be quiet

You obviously don't have a clue what your talking about . Try listening to the presentation and you will understand better rather than make silly comments . The fact apta s optimer can be used across multiple species without modification is a huge plus and cost saving as no need to further develop for each category .

If you don't know what your talking about don't say anything

Still some churn going on from the placing ,taking longer than other shares to clear but once it does this will fly imo . Look at others that have done the same and once it's cleared they move quickly and on a lot less than polx has already . Sit tight and wait ,you will be rewarded handsomely imo .

I'm interested to know what you think the risks are at this level . Not trying to be awkward but they way I see it is they are fully funded until mid 2026;so no issues with cash or raises . They are dealing with 15 of the top 20 pharma companies in the world , yes works not UK ,not EU. Basically you have over a year and a half for apta to announce deals and good news on licensing fees with virtually no risk from these levels . Any such news will see this head higher with a mkt cap of 5m and 3 m in cash .

A licensing deal with any of those 15 companies

is likely to lead to millions of pounds in recurring revenue which will make the current mkt cap look ridiculous .

I appreciate there is always risk with stocks but compared to most this isn't at the higher end of them . I would say. Bt or blank stocks carry a much higher risk than this does at present .

As always dyor

There is very real potential for one or more of these to generate initial (albeit modest) payments as early as this financial year, with potential to multiply quite dramatically thereafter. Seemingly unrecognised in the Group’s current valuation, any such breakthrough adoption would be transformative for the Group both financially and in terms of reputation. Yet, based simply on the current trajectory of new FFS work being sustained along with this year’s expected scaling back of its cost base, the Board considers last July’s fundraise (plus annual R&D tax credit) will be sufficient to satisfy working capital needs out to mid-2026, by which time anticipated receipt of licensing fees should enable the Group to become financially self sustaining.

So a long cash runway and huge potential . Valued at 5m with around 3m in cash in the bank . I've seen much poorer companies worth multiples of this mkt cap and that's without the potential

2 were corrections the other a worked but 52m at 0.275p . Looking good expect it to rise this week

Expecting a big week or two here could see this move back to previous levels in a hurry . The buying the last few days has increased and selling slowed . Won't take much for this to jump 50-100% In a day imo . Doesn't make much difference the real gains will be on a licensing deal with Unilever or AZ that will make any price look cheap

Someone bought 52.5m shares at 27.5p that's going to be a huge bounce come monday lol . Think someone missed a decimal place or two as that's more than the company y is worth x4

It's weekend tomorrow it won't move at all but hopefully maybe some press and next week I expect to see a big rise or two as people start to catch on . This is so undervalued it's comical and easy money . Funded until at least mid 2026 .

Mkt cap 5m with around 3m in the bank and 15 of the top 30 pharma companies as clients . Dyor this is going to move rapidly

Plenty of interest there as they are working with 15 of the top 20 pharma companies in the world ,many of which are American . This is a little gem in hiding ,those getting in at these levels will do very well in a year or two imo

Just to add they announced 471k of deals yesterday yet state the pipeline is still 4m which shows that the pipeline continues to grow and stood at 4.5m up from the 4m announced recently .

The real big deal will be a license deal with either Unilever or AZ though and could be worth double digit millions .

There are approximately 50,000 MRI scanners in hospitals and clinics worldwide, and over 100 million MRI scans are performed annually. The density of MRI units per million people can be used to measure the quality of a country's health care infrastructure.

We currently have 26 sites it's not hard to see why this could be a huge multibagger. . Those 26 sites have resulted in over 3m in revenues alone so far .

The potential here is huge even if they capture a small percentage of those the revenues will be huge to polx and will likely see it taken over for many multiples of the current mkt cap .

One thing at a time and first is get to break even which should happen in 12-18 months hopefully . That will be a huge step

Good news today yet another endorsement and increasing revenues with major companies . There are companies worth multiples of aptas mkt cap with revenues at or lower . This is grossly undervalued and will extend the cash runway further too . More deals to come too this should rerate sooner or later

That has to be a really bad sign . He's only been there 7 weeks and seen that it's beyond help and saving and ran off in a hurry so it doesn't blot his resume . The writing is on the wall I'm afraid now

I think the figure for tax refund is over a million next year ,1?2m springs to mind . I agree Gino could do with making a statement as to his priorities and cash burn etc the silence since cheeks quick removal with no indication of direction is not helping clarity .

Gino is the brains behind gdr that's quite obvious however his experience of running a business with investors and market conditions is limited from what I can see and advising on his ideas would be of interest ..

I still believe the move was part of a bigger plan resulting in gdr being taken over eventually .

Spot on Stephen ,I actually think ash burn will be slightly lower but there is no problem until late next year and by then lots will have happened that could see the SP much higher . FDA approval for one .

Personally I think it will have been bought out well before then for around 10p as soon as FDA hits the US partner will swoop to buy it

My thoughts are it seems to be a new technique to make the last trade look like a buy to try and entice more buying so someone can sell bigger chunks and vice versa. Isn't just happening on apta have seen it on a few shares and seems something that institutions employ when they are trying to buy?/sell mto control the SP . Justy opinion nothing concrete but something I have seen happening and why I think it's occuring

Silly comment the downside is 100% from here and that is the most likely outcome and why it is values so low . The odds are against it surviving . The main issue at present is funding and ability to raise money . They need a lot of it and with such a low melt cap that isn't possible . Either way iits likely to be highly dillutive again and wipe out holders even ones that have bought recently .

Other options remain and even if they can raise funds there are a lot of issues and risks that remain . It's 0.25p for good reason

Unlikely as AN didn't want to work with them as it was too difficult to find anyone to make a decision . Perhaps if you knew this company and it's history you might actually understand things better rather than posting random garbage emerald